Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Candidiasis,Inverse variance weighted,19,1.00 [0.89-1.14],0.939145636264537
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,19,0.99 [0.95-1.03],0.617216926996606
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,19,1.00 [0.97-1.03],0.888045187570961
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,19,0.98 [0.89-1.07],0.615086577216274
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,19,1.02 [0.99-1.06],0.170529971467069
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,19,0.97 [0.66-1.42],0.857690886789515
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,19,1.03 [0.96-1.11],0.397163672346501
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Other viral diseases,Inverse variance weighted,19,1.09 [1.02-1.16],0.0104475134772948
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,19,0.78 [0.47-1.30],0.334392568481755
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,Inverse variance weighted,19,0.95 [0.73-1.25],0.724107819252571
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",Inverse variance weighted,19,1.10 [1.01-1.19],0.0236144986803933
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,Inverse variance weighted,19,0.94 [0.88-1.02],0.130701137553527
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,Inverse variance weighted,19,1.01 [0.96-1.06],0.745354966594251
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,19,1.03 [0.98-1.09],0.210605870637771
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,19,1.16 [0.94-1.43],0.158678726510086
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",Inverse variance weighted,19,1.04 [0.86-1.26],0.703755076791251
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,Inverse variance weighted,19,1.00 [0.89-1.12],0.963926219998925
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,19,0.81 [0.66-0.99],0.0403468070029887
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Crohn's disease NAS,Inverse variance weighted,19,1.18 [1.01-1.38],0.0343842505855755
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,19,1.06 [0.97-1.15],0.2253575199159
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Later onset COPD,Inverse variance weighted,19,0.99 [0.93-1.06],0.732858105300426
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,Inverse variance weighted,19,1.09 [0.98-1.22],0.130602155127546
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,Inverse variance weighted,19,1.44 [0.90-2.30],0.127467742319759
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,19,0.83 [0.63-1.08],0.164825753533662
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,19,0.97 [0.91-1.03],0.290444342562411
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,19,0.97 [0.91-1.03],0.331697089257287
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,Inverse variance weighted,19,1.34 [1.16-1.54],7.75917597757703e-05
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,Inverse variance weighted,19,0.98 [0.61-1.58],0.944228251915297
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,Inverse variance weighted,19,0.87 [0.76-1.01],0.0726707920816846
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,19,0.91 [0.82-1.02],0.100899871994419
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,Inverse variance weighted,19,0.99 [0.86-1.14],0.901445464524121
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,Inverse variance weighted,19,0.74 [0.54-1.01],0.061075357439247
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,19,0.88 [0.76-1.02],0.0931318240490193
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,19,0.93 [0.82-1.06],0.303663556026213
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,19,0.96 [0.85-1.09],0.539197164308335
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,19,1.00 [0.75-1.33],0.982486735126247
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,19,1.02 [0.86-1.20],0.853776043363746
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,19,0.90 [0.78-1.03],0.112802755919387
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,19,0.90 [0.79-1.03],0.111568436150849
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,19,0.97 [0.92-1.03],0.339494818132146
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",Inverse variance weighted,19,0.98 [0.88-1.09],0.693147267499093
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,Inverse variance weighted,19,0.86 [0.57-1.30],0.476902792946188
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,19,0.99 [0.93-1.06],0.855714512559379
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,19,0.98 [0.86-1.10],0.697376871435543
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,19,0.88 [0.74-1.06],0.190861995480675
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,19,1.02 [0.96-1.08],0.546858309990149
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,Inverse variance weighted,19,0.91 [0.61-1.34],0.632274902531527
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,19,1.01 [0.91-1.12],0.850402404654003
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,Inverse variance weighted,19,1.14 [1.02-1.27],0.0199135499649592
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,19,0.96 [0.88-1.05],0.419859547260904
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,19,0.99 [0.95-1.03],0.555592915339987
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,19,1.00 [0.97-1.03],0.93144348355982
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,Inverse variance weighted,19,1.03 [0.62-1.70],0.917984500026219
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,19,1.08 [0.94-1.23],0.273715991594153
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,19,1.02 [0.93-1.11],0.715786890495982
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",Inverse variance weighted,19,1.49 [0.93-2.40],0.099690059490115
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,19,1.00 [0.96-1.04],0.968708836081717
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,Inverse variance weighted,19,0.98 [0.68-1.43],0.929519080209845
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,19,0.92 [0.81-1.04],0.163259229298846
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",Inverse variance weighted,19,1.17 [1.04-1.31],0.0079258026542232
RELT,Tumor necrosis factor receptor superfamily member 19L,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,19,1.01 [0.97-1.04],0.745830906937597
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,19,1.00 [0.97-1.04],0.749115982395337
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,19,0.99 [0.97-1.02],0.576305224922582
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter VI Diseases of the nervous system,Hemiplegia,Inverse variance weighted,19,0.93 [0.80-1.10],0.399555208395333
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,19,1.04 [0.93-1.17],0.494517502553183
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,19,0.96 [0.88-1.05],0.339989547433154
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,Inverse variance weighted,19,1.02 [0.98-1.05],0.31502913313605
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),Inverse variance weighted,19,1.00 [0.88-1.13],0.980403035017489
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,19,0.96 [0.90-1.03],0.2963973129144
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,19,0.98 [0.93-1.04],0.542465106836159
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Aortic aneurysm,Inverse variance weighted,19,1.06 [0.96-1.17],0.276617913381306
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,Inverse variance weighted,19,1.08 [0.89-1.32],0.432058563045974
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,Inverse variance weighted,19,1.01 [0.81-1.25],0.954474825898192
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,19,1.02 [0.91-1.15],0.717462874958512
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,19,1.00 [0.94-1.06],0.971456120095292
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,AV-block,Inverse variance weighted,19,0.96 [0.87-1.06],0.412638703163558
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,19,0.97 [0.80-1.18],0.780299296440456
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Cardiomyopathy,Inverse variance weighted,19,0.93 [0.86-1.01],0.0923377876453287
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",Inverse variance weighted,19,0.96 [0.84-1.10],0.535840115657027
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",Inverse variance weighted,19,1.09 [0.94-1.25],0.246315867627793
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,19,0.95 [0.90-0.99],0.0293321093123283
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,19,0.95 [0.89-1.02],0.140203989308362
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,19,0.98 [0.94-1.03],0.431824892517218
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Endocarditis,Inverse variance weighted,19,0.86 [0.70-1.05],0.139595247354365
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,19,0.97 [0.92-1.02],0.224233515956816
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,19,1.08 [0.99-1.19],0.0967680278365749
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,19,0.96 [0.92-1.00],0.0558625793104222
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,19,0.96 [0.92-1.01],0.0809553893872237
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,19,0.75 [0.50-1.13],0.170879718561938
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,19,1.04 [0.80-1.34],0.789744539485748
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,19,0.97 [0.94-1.01],0.190951876618014
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,19,0.98 [0.93-1.03],0.443611127157151
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Left bundle-branch block,Inverse variance weighted,19,0.91 [0.79-1.05],0.21358746063177
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,19,0.92 [0.87-0.98],0.0094112919659502
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Other arrhythmias,Inverse variance weighted,19,0.98 [0.94-1.02],0.357262154267319
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,19,1.10 [0.91-1.34],0.31497367705613
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,19,0.94 [0.72-1.22],0.64370934674775
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,19,1.00 [0.88-1.14],0.978559822670363
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,19,0.99 [0.92-1.07],0.7907058284977
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,Inverse variance weighted,19,1.01 [0.84-1.22],0.910193774037623
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,DVT of lower extremities,Inverse variance weighted,19,1.05 [0.98-1.12],0.181558520714148
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),Inverse variance weighted,19,1.07 [0.96-1.19],0.230477962480651
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Pulmonary embolism,Inverse variance weighted,19,1.04 [0.97-1.12],0.230623420043929
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Right bundle-branch block,Inverse variance weighted,19,1.02 [0.83-1.25],0.832496450718626
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,19,1.32 [1.03-1.70],0.0270862977515476
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,19,1.08 [0.89-1.31],0.424299809126072
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,Inverse variance weighted,19,0.98 [0.92-1.04],0.455454265037101
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,19,1.01 [0.96-1.06],0.746347709689809
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,19,1.02 [0.81-1.29],0.869063603177172
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,19,1.05 [0.99-1.11],0.0832709989230715
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,19,1.07 [0.95-1.21],0.271812586468915
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),Inverse variance weighted,19,0.99 [0.89-1.11],0.852565152218685
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,19,1.14 [0.97-1.34],0.101638991581022
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,19,0.92 [0.83-1.01],0.0812321948387442
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,Inverse variance weighted,19,1.06 [1.02-1.09],0.0024144514972223
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,19,1.01 [0.96-1.06],0.838260242302118
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Bronchiectasis,Inverse variance weighted,19,1.05 [0.92-1.21],0.443886247954474
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Emphysema,Inverse variance weighted,19,0.97 [0.84-1.13],0.727096672047964
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,Inverse variance weighted,19,1.04 [0.94-1.14],0.453277460056765
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,All influenza,Inverse variance weighted,19,1.01 [0.94-1.08],0.86256602681263
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,19,1.03 [1.00-1.06],0.0737249343545604
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,19,1.00 [0.96-1.03],0.905537556021812
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,19,1.01 [0.96-1.05],0.711519952929062
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,19,1.00 [0.95-1.06],0.945362027577778
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,19,1.04 [0.94-1.14],0.447139369747331
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Pleural plaque,Inverse variance weighted,19,1.07 [0.92-1.24],0.38232942836182
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,Inverse variance weighted,19,0.99 [0.87-1.13],0.904354555999454
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,19,0.96 [0.72-1.28],0.774084200661341
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,Viral pneumonia,Inverse variance weighted,19,1.07 [0.94-1.22],0.282844712197864
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,Inverse variance weighted,19,1.07 [1.03-1.12],0.0005391151121361
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Cholelithiasis,Inverse variance weighted,19,0.98 [0.94-1.02],0.316137069088611
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,19,1.03 [0.99-1.06],0.155023025029433
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,Inverse variance weighted,19,1.09 [0.99-1.21],0.076045136225673
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,19,1.05 [0.96-1.14],0.311976405893384
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,Inverse variance weighted,19,1.02 [0.97-1.07],0.453340479145074
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,19,1.01 [0.94-1.08],0.809300778564964
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,19,0.90 [0.76-1.07],0.248131921289273
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,19,1.03 [0.84-1.27],0.743527295599319
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Hernia,Inverse variance weighted,19,1.07 [0.99-1.15],0.0921791127032013
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,Inverse variance weighted,19,1.07 [0.97-1.17],0.170300611910768
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,19,0.99 [0.96-1.03],0.765854359936292
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,19,1.03 [0.97-1.10],0.281637418024458
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Oesophagitis,Inverse variance weighted,19,1.10 [0.94-1.29],0.240406252648168
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,19,0.98 [0.95-1.01],0.200536652963629
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,19,0.95 [0.90-1.01],0.12846163254032
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,Inverse variance weighted,19,0.96 [0.90-1.03],0.256762986370372
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,19,1.00 [0.84-1.18],0.983276514467712
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,19,0.98 [0.92-1.05],0.622574724113681
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,19,1.02 [0.96-1.08],0.533152861259316
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,19,1.00 [0.90-1.10],0.925836066624444
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",Inverse variance weighted,19,1.07 [0.98-1.17],0.133724861050896
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,19,1.04 [0.89-1.22],0.599049107297466
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Other diseases of intestine,Inverse variance weighted,19,0.95 [0.85-1.06],0.353946936976688
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Other diseases of pancreas,Inverse variance weighted,19,0.99 [0.84-1.16],0.856640320149731
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Acute peritonitis,Inverse variance weighted,19,1.09 [0.94-1.26],0.276040994290125
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Diseases of peritoneum,Inverse variance weighted,19,1.03 [0.92-1.15],0.593979914284473
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,Inverse variance weighted,19,0.99 [0.95-1.03],0.697954756511134
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,19,0.99 [0.96-1.03],0.734452743420059
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,19,1.02 [0.95-1.09],0.60762316275513
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,19,1.01 [0.92-1.11],0.828689891205787
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,19,0.98 [0.81-1.18],0.813763737113447
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,Inverse variance weighted,19,1.01 [0.97-1.06],0.588181319531765
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,19,1.01 [0.96-1.07],0.650963993802971
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,Inverse variance weighted,19,1.08 [0.85-1.38],0.525572624799073
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,19,0.96 [0.93-1.01],0.0929546291701025
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,19,1.01 [0.90-1.13],0.906438894662137
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,19,1.04 [1.00-1.08],0.0374163651235106
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,19,1.01 [0.94-1.08],0.82417843288286
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,Inverse variance weighted,19,1.03 [0.97-1.10],0.330342515978846
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,19,1.01 [0.99-1.03],0.444916856726685
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",Inverse variance weighted,19,1.01 [0.99-1.04],0.357749212789513
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,19,1.05 [0.97-1.12],0.22310488829591
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,Inverse variance weighted,19,1.05 [1.01-1.09],0.0189927158619096
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,19,1.03 [0.99-1.08],0.179588197998943
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,Inverse variance weighted,19,1.02 [0.88-1.18],0.828095830891339
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,19,1.07 [0.99-1.16],0.0817215493983102
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,Inverse variance weighted,19,1.05 [1.00-1.10],0.0438458127387896
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,19,1.05 [1.01-1.10],0.0072219030483781
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,19,1.09 [1.03-1.16],0.003501767832108
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],Inverse variance weighted,19,0.95 [0.83-1.07],0.379132787985156
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,Inverse variance weighted,19,1.03 [1.00-1.06],0.0728635479872721
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,Inverse variance weighted,19,1.07 [0.91-1.26],0.433864394250189
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,19,1.04 [1.00-1.07],0.0259253033339026
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,19,0.93 [0.86-1.02],0.10922313158116
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,19,0.98 [0.81-1.18],0.821376342572844
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,19,1.00 [0.93-1.07],0.907653142880598
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,Inverse variance weighted,19,1.10 [0.95-1.29],0.198834931958993
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,19,0.89 [0.73-1.09],0.26685064052258
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,19,0.88 [0.78-0.99],0.0285473192148922
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,Inverse variance weighted,19,1.16 [1.04-1.30],0.0072599509003623
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,19,0.97 [0.87-1.07],0.514851996745859
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,Inverse variance weighted,19,1.10 [0.99-1.21],0.0795534329077988
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,Inverse variance weighted,19,0.77 [0.61-0.96],0.0229420402214438
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,Inverse variance weighted,19,1.21 [0.79-1.86],0.373140741422493
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,19,1.01 [0.98-1.05],0.43886912481587
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,19,0.92 [0.81-1.04],0.170857483241257
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",Inverse variance weighted,19,0.96 [0.83-1.11],0.602320369939198
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,19,1.06 [1.01-1.12],0.02827003658033
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,19,1.04 [1.00-1.08],0.0669657651766691
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,Inverse variance weighted,19,0.94 [0.79-1.12],0.501073499177912
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,19,1.01 [0.91-1.12],0.851252260138396
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,19,1.06 [0.98-1.15],0.176259803159381
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,19,0.94 [0.82-1.09],0.426070393657899
RELT,Tumor necrosis factor receptor superfamily member 19L,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",Inverse variance weighted,19,1.05 [0.89-1.23],0.58972902209081
